We are currently in the process of updating our website to enhance user experience and provide the latest information to our visitors.
What We Do
Develop Innovative Therapy for unmet needs of patients
RockGen is a start-up biotechnology pharmaceutical company with innovative goals to develop efficacious treatments for patients suffering from neurodegenerative diseases. We utilize cutting-edge research in our investigation of the diseases of the central nervous system for developing novel and disease-modifying medicine. Amyotrophic Lateral Sclerosis will be our first to develop an effective therapy.
Drug Development and Testing
At RockGen we use proprietary compounds and their evaluations in pre-clinical models of central nervous system diseases. The main goal is to develop efficacious compounds as drugs for testing in clinical trials.
Pharmaceutical Manufacturing
At RockGen we use innovative chemistry to develop pro-drugs and analogs using wet laboratory and in silico systems to expand our pipelines and expedite drug development.
Subscribe
To be updated on our latest services, new treatments for ALS and news we announce, please subscribe
Copyright © 2024 RockGen Therapeutics, LLC - All Rights Reserved